CDKN2A and Down syndrome: As ANRIL was localised within the 403 kb deletion in the French melanoma-NST family (Bahuau et al, 1998), it has been hypothesized that this new gene could be involved melanoma-NST syndrome families and in melanoma-prone families with no identified CDKN2A mutations.